165 related articles for article (PubMed ID: 21800051)
1. The interaction between ubiquitin C-terminal hydrolase 37 and glucose-regulated protein 78 in hepatocellular carcinoma.
Fang Y; Mu J; Ma Y; Ma D; Fu D; Shen X
Mol Cell Biochem; 2012 Jan; 359(1-2):59-66. PubMed ID: 21800051
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin C-terminal Hydrolase 37, a novel predictor for hepatocellular carcinoma recurrence, promotes cell migration and invasion via interacting and deubiquitinating PRP19.
Fang Y; Fu D; Tang W; Cai Y; Ma D; Wang H; Xue R; Liu T; Huang X; Dong L; Wu H; Shen X
Biochim Biophys Acta; 2013 Mar; 1833(3):559-72. PubMed ID: 23220010
[TBL] [Abstract][Full Text] [Related]
3. The potential role of ubiquitin c-terminal hydrolases in oncogenesis.
Fang Y; Fu D; Shen XZ
Biochim Biophys Acta; 2010 Aug; 1806(1):1-6. PubMed ID: 20302916
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the de-ubiquitinating enzyme UCH37 (human UCH-L5) catalytic domain.
Nishio K; Kim SW; Kawai K; Mizushima T; Yamane T; Hamazaki J; Murata S; Tanaka K; Morimoto Y
Biochem Biophys Res Commun; 2009 Dec; 390(3):855-60. PubMed ID: 19836345
[TBL] [Abstract][Full Text] [Related]
5. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.
Luk JM; Lam CT; Siu AF; Lam BY; Ng IO; Hu MY; Che CM; Fan ST
Proteomics; 2006 Feb; 6(3):1049-57. PubMed ID: 16400691
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin carboxyl-terminal hydrolases: involvement in cancer progression and clinical implications.
Fang Y; Shen X
Cancer Metastasis Rev; 2017 Dec; 36(4):669-682. PubMed ID: 29080080
[TBL] [Abstract][Full Text] [Related]
7. Activity profiling of deubiquitinating enzymes in cervical carcinoma biopsies and cell lines.
Rolén U; Kobzeva V; Gasparjan N; Ovaa H; Winberg G; Kisseljov F; Masucci MG
Mol Carcinog; 2006 Apr; 45(4):260-9. PubMed ID: 16402389
[TBL] [Abstract][Full Text] [Related]
8. Expression of heat shock proteins (HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules.
Lim SO; Park SG; Yoo JH; Park YM; Kim HJ; Jang KT; Cho JW; Yoo BC; Jung GH; Park CK
World J Gastroenterol; 2005 Apr; 11(14):2072-9. PubMed ID: 15810071
[TBL] [Abstract][Full Text] [Related]
9. Effect of ubiquitin carboxy-terminal hydrolase 37 on apoptotic in A549 cells.
Chen Z; Niu X; Li Z; Yu Y; Ye X; Lu S; Chen Z
Cell Biochem Funct; 2011 Mar; 29(2):142-8. PubMed ID: 21287580
[TBL] [Abstract][Full Text] [Related]
10. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin dimers control the hydrolase activity of UCH-L3.
Setsuie R; Sakurai M; Sakaguchi Y; Wada K
Neurochem Int; 2009; 54(5-6):314-21. PubMed ID: 19154770
[TBL] [Abstract][Full Text] [Related]
12. Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrm1.
Yao T; Song L; Xu W; DeMartino GN; Florens L; Swanson SK; Washburn MP; Conaway RC; Conaway JW; Cohen RE
Nat Cell Biol; 2006 Sep; 8(9):994-1002. PubMed ID: 16906146
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin C-Terminal Hydrolase L1 is required for regulated protein degradation through the ubiquitin proteasome system in kidney.
Radón V; Czesla M; Reichelt J; Fehlert J; Hammel A; Rosendahl A; Knop JH; Wiech T; Wenzel UO; Sachs M; Reinicke AT; Stahl RAK; Meyer-Schwesinger C
Kidney Int; 2018 Jan; 93(1):110-127. PubMed ID: 28754552
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin Carboxyl-Terminal Hydrolases (UCHs): Potential Mediators for Cancer and Neurodegeneration.
Sharma A; Liu H; Tobar-Tosse F; Chand Dakal T; Ludwig M; Holz FG; Loeffler KU; Wüllner U; Herwig-Carl MC
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486284
[TBL] [Abstract][Full Text] [Related]
15. Interaction of the ubiquitin carboxyl terminal esterase L1 with alpha(2)-adrenergic receptors inhibits agonist-mediated p44/42 MAP kinase activation.
Weber B; Schaper C; Wang Y; Scholz J; Bein B
Cell Signal; 2009 Oct; 21(10):1513-21. PubMed ID: 19477270
[TBL] [Abstract][Full Text] [Related]
16. Regulation of synaptic structure by ubiquitin C-terminal hydrolase L1.
Cartier AE; Djakovic SN; Salehi A; Wilson SM; Masliah E; Patrick GN
J Neurosci; 2009 Jun; 29(24):7857-68. PubMed ID: 19535597
[TBL] [Abstract][Full Text] [Related]
17. Proteomic profiling of heat shock protein 70 family members as biomarkers for hepatitis C virus-related hepatocellular carcinoma.
Takashima M; Kuramitsu Y; Yokoyama Y; Iizuka N; Toda T; Sakaida I; Okita K; Oka M; Nakamura K
Proteomics; 2003 Dec; 3(12):2487-93. PubMed ID: 14673798
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.
Yu J; Tao Q; Cheung KF; Jin H; Poon FF; Wang X; Li H; Cheng YY; Röcken C; Ebert MP; Chan AT; Sung JJ
Hepatology; 2008 Aug; 48(2):508-18. PubMed ID: 18666234
[TBL] [Abstract][Full Text] [Related]
19. [Expression of UCH-L3 in mouse hepatocarcinoma ascites cell lines Hca-F and Hca-P].
Zhang ZQ; Tang JW; Sun CR
Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):273-4. PubMed ID: 19575902
[No Abstract] [Full Text] [Related]
20. Proteomic Analysis of Hippocampus in a Mouse Model of Depression Reveals Neuroprotective Function of Ubiquitin C-terminal Hydrolase L1 (UCH-L1) via Stress-induced Cysteine Oxidative Modifications.
Choi JE; Lee JJ; Kang W; Kim HJ; Cho JH; Han PL; Lee KJ
Mol Cell Proteomics; 2018 Sep; 17(9):1803-1823. PubMed ID: 29959188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
